U.S. scientists have used reverse genetics to develop an influenza virus with two key proteins on its surface derived from the H5N1 avian virus strain.
As nations stockpile vaccines against H5N1, the strain of influenza virus that experts fear could cause the next flu pandemic, researchers are unsure if the vaccines will remain effective as the virus mutates.
Dr. Elena Govorkova, Robert Webster and colleagues at St. Jude Children's Research Hospital in Memphis, say they inactivated the virus and used it to vaccinate ferrets.
They said the vaccine protected ferrets from becoming sick when exposed not only to the flu strain from which the vaccine was made, but also two other strains, including a deadly strain labeled A/Vietnam/1203/04.
Cross-strain protection is what would been needed in a pandemic, since it would protect against newly emerging variants until a strain-specific vaccine could be developed.
The scientists said the reverse genetics method they used would allow rapid vaccine preparation, which would be crucial in a fast-moving pandemic.
The study will appear in the July 15 issue of The Journal of Infectious Diseases and is available online.
Copyright 2006 by United Press International
Related stories:
New study determines double flu jab needed against bird flu pandemic
An international study led by University of Leicester researchers has determined that vaccination will be the best way to protect people in the event of the next influenza pandemic – but that each person would need two doses.
Flu vaccine not associated with reduced hospitalizations or outpatient visits among young children
Use of the influenza vaccine was not associated with preventing hospitalizations or reducing physician visits for the flu in children age 5 and younger during two recent seasons, perhaps because the strains of virus in the vaccine did not match circulating strains, according to a report in the October issue of
Archives of Pediatrics & Adolescent Medicine, one of the
JAMA/Archives journals.
A DNA-based vaccine shows promise against avian flu
(PhysOrg.com) -- Though it has fallen from the headlines, a global pandemic caused by bird flu still has the United States’ Centers for Disease Control and Prevention on high alert. Yet, to date, the only vaccines that have proven even semi-effective are produced in chicken eggs, take five to six months to prepare and act against a single variant of the H5N1 virus, which mutates incredibly quickly. Now, new research by scientists in New York and Taiwan has led to a vaccine with the potential to stop most strains of H5N1 flu viruses in their tracks.
Human trials of universal flu vaccine begin
Clinical trials of a new vaccine that could protect against multiple types of flu are beginning at Oxford University. If successful, the ‘universal’ flu injection would transform the way we vaccinate against influenza and could offer immunity to a bird flu pandemic.
Towards understanding bluetongue outbreaks
A recent article published in
Virology, reports the identification of a bluetongue virus strain that caused the northern European Bluetongue outbreak in 2006. Comparison of the virus strain with the sequences of other previously isolated strains showed that it originated in sub-Saharan Africa, rather than from vaccine strains or strains circulating in southern Europe.
Trapping white blood cells proves novel strategy against chronic viral infections
Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found.
Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs
AIDS experts at Johns Hopkins say they have compelling evidence that some people with HIV who for years and even decades show extremely low levels of the virus in their blood never progress to full-blown AIDS and remain symptom free even without treatment, probably do so because of the strength of their immune systems, not any defects in the strain of HIV that infected them in the first place.
Viral recombination another way HIV fools the immune system
When individuals infected with HIV become infected with a second strain of the virus, the two viral strains can exchange genetic information, creating a third, recombinant strain of the virus. It is known that the presence of multiple viral strains, called superinfection, frequently leads to a loss of immune control of viral levels. Now a study from the Partners AIDS Research Center at Massachusetts General Hospital (PARC/MGH) shows that how and where viral strains swap DNA may be determined by the immune response against the original infecting strain. Their report will appear in the
Journal of Experimental Medicine and has been released online.